Pfizer (PFE) Market Capitalization (2009 - 2026)

Pfizer (PFE) has reported Market Capitalization for 18 consecutive years, with $138.4 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Market Capitalization rose 0.66% year-over-year to $138.4 billion in Q2 2026; TTM through Jun 2026 was $138.4 billion, a 0.66% increase from a year earlier, with the FY2025 full-year figure at $141.6 billion, down 5.83% from the prior year.
• Market Capitalization was $138.4 billion for Q2 2026 at Pfizer, down from $154.1 billion in the prior quarter.
• Over five years, Market Capitalization peaked at $293.6 billion in Q3 2022 and troughed at $135.1 billion in Q3 2025.
• A 5-year average of $188.0 billion and a median of $160.6 billion in 2023 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization surged 42.4% in 2022 and tumbled 43.54% in 2023, its largest moves.
• Over 5 years, Market Capitalization stood at $287.9 billion in 2022, then tumbled by 43.54% to $162.6 billion in 2023, then retreated by 7.51% to $150.4 billion in 2024, then retreated by 5.83% to $141.6 billion in 2025, then decreased by 2.22% to $138.4 billion in 2026.
• The last three Market Capitalization figures came in at $138.4 billion (Q2 2026), $154.1 billion (Q1 2026), and $141.6 billion (Q4 2025), per Business Quant data.